Robert Andtbacka, MD, associate professor, Division of Surgical Oncology Department of Surgery, University of Utah School of Medicine, discusses past, present, and future trials for T-VEC.
Robert Andtbacka, MD
Advertisement
Articles by Robert Andtbacka, MD
Robert Andtbacka, MD, from University of Utah School of Medicine, discusses the management of side effects from T-VEC.
Advertisement
Latest Updated Articles
Robert Andtbacka on Managing Side Effects From T-VECFebruary 24th 2016
- Robert Andtbacka Discusses T-VEC Trials
April 20th 2016
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Managing Rash and Stomatitis With Daraxonrasib in Pancreatic Cancer
2
FDA Approves Oral Nilotinib Tablets for Ph+ CML
3
Nursing Guide to Managing Lorlatinib in ALK+ NSCLC: 7-Year CROWN Insights
4
GLP-1 RAs Linked to Lower HR+ Breast Cancer Risk and Improved Survival
5